Li-Ping Su - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Li-Ping Su

Showing results (61-70 of 65) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 65 results.

The Lancet. Haematology|May 26, 2019

Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trialPeng-Peng Xu, Di Fu, Jian-Yong Li, et al.

Blood Advances|November 3, 2023

Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairmentYuan Jian, Long Chang, Ming-Xia Shi, et al.

The Lancet Regional Health. Western Pacific|June 7, 2023

A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteriaLu Zhang, Yu-Jun Dong, Hong-Ling Peng, et al.

JAMA|April 22, 2026

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical TrialPeng-Peng Xu, Yu-Qin Song, Jian-Zhen Shen, et al.

Science Bulletin|August 20, 2023

A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort studyZhuo-Yu An, Ye-Jun Wu, Yu Hou, et al.

Pageof 7

Search research articles

Showing results (61-70 of 65) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 65 results.

The Lancet. Haematology|May 26, 2019

Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trialPeng-Peng Xu, Di Fu, Jian-Yong Li, et al.

Blood Advances|November 3, 2023

Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairmentYuan Jian, Long Chang, Ming-Xia Shi, et al.

The Lancet Regional Health. Western Pacific|June 7, 2023

A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteriaLu Zhang, Yu-Jun Dong, Hong-Ling Peng, et al.

JAMA|April 22, 2026

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical TrialPeng-Peng Xu, Yu-Qin Song, Jian-Zhen Shen, et al.

Science Bulletin|August 20, 2023

A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort studyZhuo-Yu An, Ye-Jun Wu, Yu Hou, et al.

Pageof 7